EMCDDA Home
  • EN
Search

Drugnet Europe News from the European Monitoring Centre for Drugs and Drug Addiction — April–June 2007

New EMCDDA products and services

Insights No 7 cover

EMCDDA Insights No 7
Prevention of substance abuse

This latest edition in the EMCDDA’s Insights series provides information about best practice in drug prevention for all those working in the field, as well as those involved in planning and decision-making at European, national, regional and municipal level. The publication is a translation of a German study commissioned by the Federal Centre for Health Education, Cologne. While, in some sections, reference is made in particular to Germany, the publication’s conclusions are international and provide value for a pan-European and global readership. It is hoped that this publication will lead to a common European understanding of professional standards in prevention work and will accelerate the development in Member States of quality standards for prevention projects and training requirements for prevention workers.

Online review of indicated prevention

An online review of international literature on the theory and evidence base of indicated prevention will be published in early summer. Entitled 'Preventing later substance abuse disorders in identified individuals during childhood and adolescence', the review summarises research results and places special emphasis on the expanding field of neurobiological knowledge on addiction. Also presented are existing indicated prevention programmes in the EU and recommendations for further steps.

Selected issue: drug-related public expenditure

Drug-related public expenditure in Europe is the title of the first of three EMCDDA Selected issues to be published in 2008. Scheduled for launch in June, the publication reviews issues of economic evaluation theory that are key to understanding the role of both labelled and unlabelled drug-related public expenditure.

Drugs in waste water

Assessing illicit drugs in waste water: potential and limitations of a new monitoring approach will be the focus of a forthcoming edition in the EMCDDA Insights series planned for release before summer. The publication provides insights from various viewpoints on what is recently becoming known as 'wastewater sampling for drugs', 'drug wastewater analysis' and 'drug sewage epidemiology'. Contributions will be made from the perspectives of analytical chemistry, physiology and molecular biology as well as sewage engineering, spatial epidemiology and conventional drug epidemiology.

Drug profiles

Following the launch of this series last spring, the profiles of an additional five substances are currently under preparation (GHB, hallucinogenic mushrooms, ketamine, LSD and volatile substances). The profiles on hallucinogenic mushrooms and volatile substances are scheduled for publication before summer.

All new EMCDDA titles can be found on the publications page.


Drugnet Europe is the EMCDDA's newsletter launched in September 1996. The newsletter provides regular and succint information on the Centre's projects and activities to a broad readership.

Page last updated: Wednesday, 30 April 2008